Completed Access to Information Requests

Transitional Period

Federal departments are moving their web content to Canada.ca. As a part of that process, proactive disclosure reports will become available through the Open Government portal.  During this transition, if a proactive disclosure report from a specific department is not yet available on the Open Government portal please refer to Proactive disclosure by department or agency where a copy can be found.  For any questions on this issue, please contact us at open-ouvert@tbs-sct.gc.ca .

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests previously made to the Government of Canada. If you find a summary of interest, you can request a copy of the records at no cost. For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator.

Enter keywords (e.g. institution, topic, field of interest, etc.)
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Found 1892 record(s)

Req # A-2017-001432

Adverse Reaction Report (AER) for docetaxel. Report numbers: 000693705, E2B_01174998.

Organization: Health Canada

13 page(s)
April 2018

Req # A-2015-000540

Cost-benefit analysis of the plain packaging of tobacco products (1000179835). This tender was published on March 11, 2016.

Organization: Health Canada

503 page(s)
April 2018

Req # A-2016-000011

Adverse Reaction Report (AER). Report number: 000663898.

Organization: Health Canada

3 page(s)
April 2018

Req # A-2011-000006

All documents which involve Sandoz Canada from January 1, 2008 to March 20, 2012.

Organization: Health Canada

1531 page(s)
April 2018

Req # A-2016-000044

All of Actavis Pharma Company’s submissions, Drug Identification Number (DIN) 02438399 for notices of compliance for bortezomib.

Organization: Health Canada

2612 page(s)
April 2018

Req # A-2013-000065

All documents related to the Ayurvedic ingredient shilajit including a Health Canada advisory issued Mar 3, 2005 warning against use of shilajit and any adverse reaction reports connected to shilajit.

Organization: Health Canada

151 page(s)
April 2018

Req # A-2014-000164

Briefing notes in the Ministerial Executive Correspondence System (MECS) for the following files: 14-108445-894, 14-104979-188, 14-108315-135, 14-105239-342, 14-108783-952, 14-104970-947, 14-108315-135, 13-111630-635, 14-109646-4, 14-108783-952, 14-004800-617, 14-11081-817.

Organization: Health Canada

2 page(s)
April 2018

Req # A-2014-000215

Briefing material identified by tracking numbers in previous release A-2014-00864: 14-109978-693, 14-110078-634, 14-111116-903, 14-112476-224, 14-111299-435, 14-107949-825, 14-112146-395, 14-111646-725, 14-103111-394.

Organization: Health Canada

109 page(s)
April 2018

Req # A-2014-000282

Briefing notes in the Ministerial Executive Correspondence System (MECS) for the following files: 13-114993-219, 13-113701-733, 13-113248-216, 13-114251-41, 13-112732-934, 13-113136-295, 13-113258-206, 13-114182-749.

Organization: Health Canada

8 page(s)
April 2018

Req # A-2015-000067

All documents regarding the comprehensive safety review on power morcellators.

Organization: Health Canada

265 page(s)
April 2018